NCT02249871 Investigating the Influence of Omeprazole on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02243098 Investigating the Influence of Semaglutide on the Pharmacokinetics of Single Doses of Atorvastatin and Digoxin in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02231684 Investigating the Pharmacokinetics of Subcutaneous Injections With 1 mg/mL, 3 mg/mL, and 10 mg/mL Semaglutide Strengths and the Absolute Bioavailability of Semaglutide Status COMPLETED Phase PHASE1
NCT02212067 A Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT02210871 Investigating the Pharmacokinetics, Safety and Tolerability After a Single Subcutaneous Injection of Semaglutide in Subjects With Mild, Moderate or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function Status COMPLETED Phase PHASE1
NCT02207374 A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT02172313 Effect of Food on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02161588 A Trial to Assess the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Oral Semaglutide in Healthy Male Japanese and Caucasian Subjects Status COMPLETED Phase PHASE1
NCT02147431 A Trial Investigating the Effect of Semaglutide on Hypoglycaemic Counterregulation Compared to Placebo in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT02146079 A Trial to Assess the Pharmacokinetics, Pharmacodynamics, and the Safety and Tolerability of Semaglutide in Healthy Male Japanese and Caucasian Subjects Status COMPLETED Phase PHASE1
NCT02128932 Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT02079870 Trial Investigating the Effect of Semaglutide on Energy Intake, Appetite Sensations, Postprandial Glucose and Triglyceride Metabolism and Gastric Emptying in Obese Subjects Compared With Placebo Status COMPLETED Phase PHASE1
NCT02070510 A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Lisinopril and Warfarin in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02064348 A Thorough QTc Evaluation of the Effect of Semaglutide on Cardiac Repolarisation in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02060266 Trial Investigating the Absorption, Metabolism and Excretion After a Single Subcutaneous Dose of [3H]-Semaglutide in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT02054897 Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT02022254 Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02016911 Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment Status COMPLETED Phase PHASE1
NCT02014259 Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Various Degrees of Impaired Renal Function Status COMPLETED Phase PHASE1
NCT01930188 Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3